Vir Biotechnology (VIR) EBT (2018 - 2025)
Historic EBT for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$163.0 million.
- Vir Biotechnology's EBT rose 2368.03% to -$163.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$499.4 million, marking a year-over-year increase of 738.19%. This contributed to the annual value of -$523.1 million for FY2024, which is 1672.87% up from last year.
- As of Q3 2025, Vir Biotechnology's EBT stood at -$163.0 million, which was up 2368.03% from -$110.8 million recorded in Q2 2025.
- Vir Biotechnology's 5-year EBT high stood at $921.9 million for Q1 2022, and its period low was -$233.7 million during Q2 2022.
- Over the past 5 years, Vir Biotechnology's median EBT value was -$120.9 million (recorded in 2025), while the average stood at -$12.7 million.
- Examining YoY changes over the last 5 years, Vir Biotechnology's EBT showed a top increase of 64642.86% in 2022 and a maximum decrease of 47778.59% in 2022.
- Vir Biotechnology's EBT (Quarter) stood at $545.9 million in 2021, then tumbled by 127.78% to -$151.6 million in 2022, then rose by 20.36% to -$120.8 million in 2023, then increased by 13.32% to -$104.7 million in 2024, then tumbled by 55.69% to -$163.0 million in 2025.
- Its EBT stands at -$163.0 million for Q3 2025, versus -$110.8 million for Q2 2025 and -$120.9 million for Q1 2025.